| Elmyra V Encarnacion, MD | |
|
1000 E Mountain Blvd, Wilkes Barre, PA 18711-0027 | |
| (570) 808-6026 | |
| (570) 808-3208 |
| Full Name | Elmyra V Encarnacion |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 29 Years |
| Location | 1000 E Mountain Blvd, Wilkes Barre, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093762270 | NPI | - | NPPES |
| 1882268-01 | Medicaid | TX | |
| 8W9869 | Other | TX | BLUE CROSS BLUE SHIELD |
| P00455664 | Other | TX | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | N5037 (Texas) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | MD422042 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Washington Hospital | Fredericksburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mary Washington Healthcare Physicians | 2769546530 | 285 |
News Archive
The Ensign Group, Inc., announced today that it has acquired the underlying real estate and other operating assets of Orem Rehabilitation & Nursing Center, a 108-bed skilled nursing facility in Orem, Utah.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity.
Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for safe and simple handling of hazardous drugs, today announced a more than doubling of year-over-year revenue.
The new device, which was patented by researchers of the School of Industrial Engineering of the Universidad Politécnica de Madrid (UPM) in collaboration with the Universidad Autónoma de Madrid (UAM), has achieved minimizing the risks associated to emergency tracheotomies and the time needed to perform planned tracheotomies.
According to a new study, women in Europe who visit their doctor with the symptoms of possible heart disease are not taken as seriously as men.
› Verified 8 days ago
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
The Ensign Group, Inc., announced today that it has acquired the underlying real estate and other operating assets of Orem Rehabilitation & Nursing Center, a 108-bed skilled nursing facility in Orem, Utah.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity.
Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for safe and simple handling of hazardous drugs, today announced a more than doubling of year-over-year revenue.
The new device, which was patented by researchers of the School of Industrial Engineering of the Universidad Politécnica de Madrid (UPM) in collaboration with the Universidad Autónoma de Madrid (UAM), has achieved minimizing the risks associated to emergency tracheotomies and the time needed to perform planned tracheotomies.
According to a new study, women in Europe who visit their doctor with the symptoms of possible heart disease are not taken as seriously as men.
› Verified 8 days ago
| Entity Name | Mary Washington Healthcare Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295999852 PECOS PAC ID: 2769546530 Enrollment ID: O20090123000298 |
News Archive
The Ensign Group, Inc., announced today that it has acquired the underlying real estate and other operating assets of Orem Rehabilitation & Nursing Center, a 108-bed skilled nursing facility in Orem, Utah.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity.
Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for safe and simple handling of hazardous drugs, today announced a more than doubling of year-over-year revenue.
The new device, which was patented by researchers of the School of Industrial Engineering of the Universidad Politécnica de Madrid (UPM) in collaboration with the Universidad Autónoma de Madrid (UAM), has achieved minimizing the risks associated to emergency tracheotomies and the time needed to perform planned tracheotomies.
According to a new study, women in Europe who visit their doctor with the symptoms of possible heart disease are not taken as seriously as men.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elmyra V Encarnacion, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Elmyra V Encarnacion, MD 1000 E Mountain Blvd, Wilkes Barre, PA 18711-0027 Ph: (570) 808-6026 |
News Archive
The Ensign Group, Inc., announced today that it has acquired the underlying real estate and other operating assets of Orem Rehabilitation & Nursing Center, a 108-bed skilled nursing facility in Orem, Utah.
Orexigen® Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its investigational drug for the treatment of obesity.
Equashield, a leading provider of Closed System Transfer Devices (CSTDs) for safe and simple handling of hazardous drugs, today announced a more than doubling of year-over-year revenue.
The new device, which was patented by researchers of the School of Industrial Engineering of the Universidad Politécnica de Madrid (UPM) in collaboration with the Universidad Autónoma de Madrid (UAM), has achieved minimizing the risks associated to emergency tracheotomies and the time needed to perform planned tracheotomies.
According to a new study, women in Europe who visit their doctor with the symptoms of possible heart disease are not taken as seriously as men.
› Verified 8 days ago
Dr. Richard M. Somma, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-820-6028 Fax: 570-826-7943 | |
Dr. Mitchell J. Gross, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-820-6028 Fax: 570-826-7943 | |
Dr. Nada El Andary, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 East Mtn Blvd, Wilkes Barre, PA 18711 Phone: 570-808-6026 Fax: 570-808-3208 | |
Dr. Francisco Santos, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1111 E End Blvd, Wilkes Barre, PA 18711 Phone: 570-824-3521 Fax: 570-819-5147 | |
Yasser M Khorchid, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7300 Fax: 570-808-3208 | |
Holly Marie Drutarovsky, PA-C Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1000 E Mountain Blvd, Wilkes Barre, PA 18711 Phone: 570-808-7300 |